Prognostic significance of Epidermal Growth Factor Receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix

European Journal of Gynaecological Oncology

Volumn 17, Issue 4, 1996, Pages 267-270

  Altavilla, G ^a   Castellan, L ^a   Wabersich, J ^a   Marchetti, M ^a   Onnis, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

c erbB 2; Cervical adenocarcinoma; EGFR; Epidermal growth factor receptor; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; ONCOGENE C ERB; PROGNOSIS; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0029774348     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Vesterinen E., Forss M., Nieminen U.: "Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements". Gynecol. Oncol., 1989, 33, 49.
2. Leminen A., Paavonen J., Forss M. et al.: "Adenocarcinoma of the uterine cervix". Cancer, 1990, 65, 53.
3. Tamini H. K., Frigge D. C.: "Adenocarcinoma of the uterine cervix". Gynecol. Oncol., 1982, 13, 335.
4. Miller B. E., Flax D. S., Arheart K., Photopulos G.: "The presentation of adenocarcinoma of the uterine cervix". Cancer, 1993, Aug. 72, 4.
5. Schwartz S. M., Weiss N. S.: "Increased incidence of adenocarcinoma of the cervix in young women in the United States". Am. J. Epidemiol., 1986, 124, 1045.
6. Chilvers C., Mant D., Pike M. C.: "Cervical adenocarcinoma and oral contraceptives". Br. Med. J., 1987, 295, 1446.
7. Young R. H., Scully R. E.: "Invasive adenocarcinoma and related tumors of the uterine cervix". Seminars in diagnostic pathology, 1990, Vol. 7, 3, 205.
8. Anderson M.: "Premalignant and malignant disease of the cervix". In: "Obstetrical and Gynaecological patholoay". Fox H. Ed., 1987, Vol. 1, 255.
9. Hopkins M. P., Schmidt R. W., Roberts J. A. et al.: "Gland cell carcinoma (adenocarcinoma) of the cervix". Obstet. Gynecol., 1988, 72, 789.
10. Berchuck A., Rodriguez G., Kamel A., Soper J. T., Clarke-Pearson D. L., Bast R. C. Jr.: "Expression of epidermal growth factor receptor and Her-2/Neu in normal and neoplastic cervix, vulva and vagina". Obstetrics and gynecology, 1990, Vol. 76, 3, 1, 381.
11. Hale R. J., Buckley C. H., Fox H., Williams J., Wilcox F. L.: "Prognostic value of epidermal growth factor receptor expression in cervical carcinoma". Clin. Pathol., 1993, 46, 149.
12. Sato S., Ito K., Ozawa N., Yajima and Sasano H.: "Expression of c-myc. Epidermal Growth Factor Receptor and c-erb B-2 in human endometrial Carcinoma and Cervical adenocarcinoma". Tohoku J., Exp. Med., 1991, 154, 137.
13. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L.: "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene". Science, 1987, 235, 177.
14. Tsuda H., Hirohashi S., Shimosato Y., Tanaka Y., Hirota T., Tsugane S. et al., "Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients". Jpn. J. Cancer Res., 1990, 81, 327.
15. Lilleng R., Hagmar B. M., Nesland J. M.: "C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast". Modern. Pathology, 1992, Vol. 5, 1, 41.
16. Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E. et al.: "Studies of the HER-2/neu protooncogene in human breast and ovarian cancer". Science, 1989, 244, 707.
17. Sugano S., Mukai K., Tsuda H., Hirohashi S., Furuya S., Shimosato Y. et al.: "Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness". Laryngoscope, 1992, 102, 923.
18. Kihana T., Tsuda H., Teshima S., Nomoto K., Sonoda T., Matsuura S., Hirohashi S.: "Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix". Cancer, 1994, January 1, Vol. 73, No. 1.
19. Hale R. J., Buckley C. H., Fox H., Williams J.: "Prognostic value c-erbB-2 expression in uterine cervical carcinoma". F. Clin. Pathol., 1992, 45, 594.
20. Scully R. E., Bonfiglio T. A., Kurman R. J., Silverberg S. G., Wilkinson E. J.: "Histological classification of tumours of the female genital tract". WHO, 1994, 2nd Ed., 39.
21. Petterson F., ed.: "Annual report on the results of treatment in gynecological cancer". Vol. 20. Stockholm: "International Federation of Gynecology and Obstetrics", 1988, 30, 1.
22. Hsu S. M., Raine L., Fanger H.: "A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies". Am. J. Clin. Pathol., 1981, 75, 734.
23. Onnis A., Piazza M., Marchetti M. et al.: "Clinical experiences of gynaecological cancer management: a) cervical cancer". Europ. J. Gynaec. Oncol., 1991, XII, 1, 11.
24. DePriest P. D., van Nagell J. R. jr., Powell D. E.: "Microinvasive cervical cancer". Clin. Obstet. Gynecol., Dec. 1990, 33 (4), 846.
25. Copeland L. J., Silva E. G., Gershenson D. M., Morris M., Young D. C., Wharton J. T.: "Superficially invasive squamous cell carcinoma of the cervix". Gynecol. Oncol., 1992, 45, 307.
26. Benson W. L., Norris H. J.: "A critical review of the frequency of the lymph node metastasis and death from microinvasive carcinoma of the cervix". Obstet. Gynecol., May 1977, 49(5), 632.
27. Kaspar H. G., Dinh T. V., Doherty M. G., Hannigan E. V., Kumar D.: "Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix" Obstet. Gynecol., 1993, 81 (2), 296.
28. Berek J. S., Hacker N. F., Fu Y.-S. et al.: "Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival". Obstet. Gynecol., 1985, 65, 46.